Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vimal Patel

Showing results (121-130 of 123) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 123 results.
JACC. Cardiovascular Imaging|June 20, 2021
Maximal Wall Thickness Measurement in Hypertrophic Cardiomyopathy: Biomarker Variability and its Impact on Clinical CareGabriella Captur, Charlotte H Manisty, Betty Raman, et al.
Bioanalysis|April 18, 2025
Recommendations on biomarker assay validation (BAV) in tissues by GCCMoucun Yuan, Aihua Liu, Bin Xu, et al.
Bioanalysis|April 28, 2018
11th GCC Closed Forum: cumulative stability; matrix stability; immunogenicity assays; laboratory manuals; biosimilars; chiral methods; hybrid LBA/LCMS assays; fit-for-purpose validation; China Food and Drug Administration bioanalytical method validationRafiq Islam, Chad Briscoe, Joseph Bower, et al.
Pageof 13

Showing results (121-130 of 123) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 123 results.
JACC. Cardiovascular Imaging|June 20, 2021
Maximal Wall Thickness Measurement in Hypertrophic Cardiomyopathy: Biomarker Variability and its Impact on Clinical CareGabriella Captur, Charlotte H Manisty, Betty Raman, et al.
Bioanalysis|April 18, 2025
Recommendations on biomarker assay validation (BAV) in tissues by GCCMoucun Yuan, Aihua Liu, Bin Xu, et al.
Bioanalysis|April 28, 2018
11th GCC Closed Forum: cumulative stability; matrix stability; immunogenicity assays; laboratory manuals; biosimilars; chiral methods; hybrid LBA/LCMS assays; fit-for-purpose validation; China Food and Drug Administration bioanalytical method validationRafiq Islam, Chad Briscoe, Joseph Bower, et al.
Pageof 13